Furthermore, for RIPK1/3 activation and necrosome complex formation, shikonin also provoked oxidative stress in glioma, gastric, nasopharyngeal, and breast cancer cells, which inhibits growth and metastasis of cancer cells through necroptosis induction. This evidence concerns the gene RIPK1 and central nervous system cancer.